专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20110039845A1 2-AMINOQUINAZOLINE DERIVATIVE 审中-公开
标题翻译： 2-氨基喹唑啉衍生物
公开(公告)号：US20110039845A1
公开(公告)日：2011-02-17
申请号：US12988847
申请日：2009-04-23
申请人： Hajime Kashima , Tomoyuki Nishikawa , Yusuke Yamada , Toshihiro Seike , Yoshisuke Nakasato , Hiroshi Umehara
发明人： Hajime Kashima , Tomoyuki Nishikawa , Yusuke Yamada , Toshihiro Seike , Yoshisuke Nakasato , Hiroshi Umehara
IPC分类号： A61K31/517 , C07D239/84 , C07D401/10 , A61K31/5377 , C07D413/10 , C07D417/10 , C07D403/10 , C07D403/14 , C07D401/12 , C07D401/14 , C07D413/14 , A61P35/00 , A61P17/06 , A61P9/12
CPC分类号： C07D239/84 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/12 , C07D405/14 , C07D413/04 , C07D413/14 , C07D417/04
摘要： A 2-aminoquinazoline derivative represented by formula (I) {wherein R1 represents a hydrogen atom, or the like, R2 represents a hydrogen atom, R3 represents formula (II) [wherein A1 represents formula (III), or the like, R8 represents lower alkyl, or the like, and R9 represents optionally substituted aryl, or the like], R4 represents hydroxy, or the like, and R5 represents optionally substituted aryl, or the like}, or a pharmaceutically acceptable salt thereof is provided.
摘要翻译：由式（I）表示的2-氨基喹唑啉衍生物{其中R1表示氢原子等，R2表示氢原子，R3表示式（II）[其中A1表示式（III）等，R8表示低级烷基等，R9表示任意取代的芳基等，R 4表示羟基等，R 5表示任意取代的芳基等）或其药学上可接受的盐。

2. 发明授权

US07919517B2 Indazole derivatives 失效
标题翻译：吲唑衍生物
公开(公告)号：US07919517B2
公开(公告)日：2011-04-05
申请号：US12275614
申请日：2008-11-21
申请人： Yoshihisa Ohta , Fumihiko Kanai , Shinji Nara , Yutaka Kanda , Hiroshi Umehara , Yukimasa Shiotsu , Tomoki Naoe , Hitoshi Kiyoi , Keiko Kawashima , Hiromi Ando , Motoki Miyama
发明人： Yoshihisa Ohta , Fumihiko Kanai , Shinji Nara , Yutaka Kanda , Hiroshi Umehara , Yukimasa Shiotsu , Tomoki Naoe , Hitoshi Kiyoi , Keiko Kawashima , Hiromi Ando , Motoki Miyama
IPC分类号： A61K31/416 , C07D231/56
CPC分类号： C07D231/56
摘要： The present invention provides a compound represented by Formula (I): [wherein R1 represents CONR1aR1b (wherein R1a and R1b may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted ararkyl or a substituted or unsubstituted heterocyclic group, or R1a and R1b are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group) or the like, R2 represents a hydrogen atom, CONR2aR2b (wherein R2a and R2b may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted ararkyl or a substituted or unsubstituted heterocyclic group, or R2a and R2b are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group), NR2cR2d (wherein R2c and R2d may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkanoyl, substituted or unsubstituted aroyl, substituted or unsubstituted heteroaroyl, substituted or unsubstituted ararkyl, substituted or unsubstituted lower alkylsulfonyl or substituted or unsubstituted lower arylsulfonyl) or the like].
摘要翻译：本发明提供由式（I）表示的化合物：[其中R1表示CONR1aR1b（其中R1a和R1b可以相同或不同，各自表示氢原子，取代或未取代的低级烷基，取代或未取代的芳基，取代或未取代的芳基或取代或未取代的杂环基，或者R1a和R1b与相邻的氮原子一起形成取代或未取代的杂环基）等，R2表示氢原子，CONR2aR2b（其中R2a和R2b可以是各自表示氢原子，取代或未取代的低级烷基，取代或未取代的芳基，取代或未取代的芳基或取代或未取代的杂环基，或者R 2a和R 2b与相邻的氮原子一起形成取代基或未取代的杂环基），NR2cR2d（其中R2c和R2d可以相同或不同取代或未取代的杂芳酰基，取代或未取代的芳酰基，取代或未取代的低级烷基磺酰基或取代或未取代的低级芳基磺酰基）等，其中R 1表示氢原子，取代或未取代的低级烷基，取代或未取代的低级烷酰基，取代或未取代的芳酰基，。

3. 发明授权

US4866550A Magnetic recording and reproducing apparatus with selective loading of different sized magnetic tapes 失效
标题翻译：具有选择性加载不同尺寸磁带的磁记录和再现装置
公开(公告)号：US4866550A
公开(公告)日：1989-09-12
申请号：US171746
申请日：1988-03-22
申请人： Keiichi Ohashi , Hiroshi Umehara , Hajime Nagahashi
发明人： Keiichi Ohashi , Hiroshi Umehara , Hajime Nagahashi
IPC分类号： H02M7/219 , G11B15/665 , G11B15/675 , G11B25/06
CPC分类号： G11B15/6653 , G11B15/67544 , G11B15/67565 , G11B25/066
摘要： A magnetic recording and reproducing apparatus which enables selective loading of a plurality of kinds of magnetic tape cassettes of different sizes, including a slider which receives a large magnetic tape cassette horizontally from an insertion position of the large magnetic tape cassette so as to displace the large magnetic tape cassette horizontally and then, lowers the large magnetic tape cassette vertically and an adapter chassis into which a small magnetic tape cassette is fitted so as to be locked thereto. Upon detection of fitting of the small magnetic tape cassette into the adapter chassis, a magnetic tape is drawn from the small magnetic tape cassette by first and second tape drawing arms mounted on the adapter chassis and upon detection of a state in which the magnetic tape has been drawn from the small magnetic tape cassette and the slider has been displaced to a position for performing recording and reproduction, the adapter chassis is loaded onto the slider located at the position for performing recording and reproduction.
摘要翻译：一种磁记录和再现装置，其能够选择性地装载多种不同尺寸的磁带盒（1,3），包括滑块（6），滑块（6）从大的磁带盒（3）的水平插入位置使大型磁带盒（3）水平移位，然后使大型磁带盒（3）垂直移动，并将适配器底盘（14）放入小型磁带盒（1）中，）被装配以便被锁定在其上。在检测到小型磁带盒（1）装配到适配器底座（14）中时，通过第一和第二带状拉伸臂（22,23）从小型磁带盒（1）中抽出磁带（1a）安装在适配器底盘（14）上，并且在检测到磁带（1a）已经从小型磁带盒（1）中被拉出并且滑块（6）已经移位到位置（6P）的状态下执行记录和再现时，适配器底盘（14）被加载到位于位置（6P）处的用于执行记录和再现的滑块（6）上。

4. 发明申请

US20120329794A1 Ab1 KINASE INHIBITORS 审中-公开
标题翻译： Ab1激酶抑制剂
公开(公告)号：US20120329794A1
公开(公告)日：2012-12-27
申请号：US12305146
申请日：2007-06-29
申请人： Yukimasa Shiotsu , Kenichi Ishii , Hiroshi Umehara , Shiro Akinaga
发明人： Yukimasa Shiotsu , Kenichi Ishii , Hiroshi Umehara , Shiro Akinaga
IPC分类号： A61K31/416 , A61K31/4439 , C12N9/99 , A61K31/454 , A61P35/00 , A61P35/02 , A61K31/5377 , A61K31/496
CPC分类号： C07D231/56 , A61K31/416 , A61K31/4439 , A61K31/454 , A61K31/496 , A61K31/5377 , C07D401/06 , C07D403/10 , C07D413/12
摘要： The present invention provides an Abelson kinase (Abl kinase) inhibitor which comprises, as an active ingredient, an indazole derivative represented by Formula (I) (wherein R1 represents substituted or unsubstituted aryl or a substituted or unsubstituted heterocyclic group) or a pharmaceutically acceptable salt thereof,an Abl kinase inhibitor which comprises, as an active ingredient, an indazole derivative represented by Formula (Ia) [wherein R2 represents CONR4aR4b (wherein R4a and R4b may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like, or R4a and R4b are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group) or the like, and R3 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like] or a pharmaceutically acceptable salt thereof, and the like.
摘要翻译：本发明提供了一种Abelson激酶（Abl激酶）抑制剂，其包含式（I）表示的吲唑衍生物作为活性成分（其中R 1表示取代或未取代的芳基或取代或未取代的杂环基）或其药学上可接受的盐其包含作为活性成分的由式（Ia）表示的吲唑衍生物（其中R 2表示CONR 4 aR 4 b（其中R 4a和R 4b可以相同或不同，各自表示氢原子，取代或未取代的低级）的Abl激酶抑制剂烷基等，或者R4a和R4b与相邻的氮原子一起形成取代或未取代的杂环基）等，R 3表示氢原子，取代或未取代的低级烷基等，或其药学上可接受的盐等。

5. 发明授权

US5948592A Water-soluble photoresist composition 失效
标题翻译：水溶性光致抗蚀剂组合物
公开(公告)号：US5948592A
公开(公告)日：1999-09-07
申请号：US111194
申请日：1998-07-07
申请人： Hiroshi Umehara , Takateru Asano
发明人： Hiroshi Umehara , Takateru Asano
IPC分类号： G03F7/004 , C08K5/098 , C08L89/00 , C23F1/00 , G02B5/20 , G03F7/04 , H01J9/14 , G03F7/008
CPC分类号： G03F7/04 , H01L2924/0002
摘要： A water-soluble photoresist composition is provided which comprises a water-soluble photosensitive composition containing a casein component and a water-soluble photosensitive agent and at least one calcium salt of an organic acid. The photoresist composition has excellent sensitivity, resolution, and etching resistance and can be used for the production of highly refined electronic components such as shadow masks, lead frame, etc.
摘要翻译：提供一种水溶性光致抗蚀剂组合物，其包含含有酪蛋白成分和水溶性光敏剂的水溶性光敏组合物和至少一种有机酸钙盐。光致抗蚀剂组合物具有优异的灵敏度，分辨率和耐蚀刻性，并且可用于制造高精度电子部件如荫罩，引线框架等。

6. 发明授权

US07956060B2 Pyrimidine derivative compound 失效
标题翻译：嘧啶衍生物化合物
公开(公告)号：US07956060B2
公开(公告)日：2011-06-07
申请号：US10594369
申请日：2005-03-30
申请人： Hitoshi Arai , Tsutomu Matsumura , Syoichi Isami , Hiroshi Ishida , Koji Hagihara , Hiroshi Umehara , Yoshinori Yamashita , Nana Oiwa , Yukimasa Shiotsu , Tomoki Naoe , Hitoshi Kiyoi
发明人： Hitoshi Arai , Tsutomu Matsumura , Syoichi Isami , Hiroshi Ishida , Koji Hagihara , Hiroshi Umehara , Yoshinori Yamashita , Nana Oiwa , Yukimasa Shiotsu , Tomoki Naoe , Hitoshi Kiyoi
IPC分类号： C07D471/04 , C07D471/22 , C07D487/04 , C07D239/70 , C07D471/00 , C07D487/00 , C07D401/00 , C07D403/00 , C07D405/00 , C07D409/00 , C07D411/00 , C07D413/00 , C07D417/00 , C07D419/00 , A61K31/505 , A01N43/56
CPC分类号： C07D413/04 , C07D413/14
摘要： The present invention provides an antitumor agent and the like, which comprises as an active ingredient, a pyrimidine derivative represented by Formula (I): [wherein —X—Y—Z— represents —O—CR3═N— (wherein R3 represents a hydrogen atom, a substituted or unsubstituted aromatic heterocyclic group and the like) and the like, R1 represents —NR10R11 (wherein R10 and R11 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like) and the like, R2 represents —NR13R14 (wherein R13 and R14 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like)] or a pharmaceutically acceptable salt thereof.
摘要翻译：本发明提供了包含作为活性成分的式（I）所示的嘧啶衍生物的抗肿瘤剂等：[其中-X-Y-Z-表示-O-CR 3 = N-（其中R 3表示氢原子，取代或未取代的芳族杂环基等）等，R 1表示-NR 10 R 11（其中R 10和R 11可以相同或不同，各自表示氢原子，取代或未取代的低级烷基等）等等，R 2表示-NR 13 R 14（其中R 13和R 14可以相同或不同，各自表示氢原子，取代或未取代的低级烷基等）]或其药学上可接受的盐。

7. 发明申请

US20090082348A1 INDAZOLE DERIVATIVES 失效
标题翻译：吲哚衍生物
公开(公告)号：US20090082348A1
公开(公告)日：2009-03-26
申请号：US12275614
申请日：2008-11-21
申请人： Yoshihisa Ohta , Fumihiko Kanai , Shinji Nara , Yutaka Kanda , Hiroshi Umehara , Yukimasa Shiotsu , Tomoki Naoe , Hitoshi Kiyoi , Keiko Kawashima , Hiromi Ando , Motoki Miyama
发明人： Yoshihisa Ohta , Fumihiko Kanai , Shinji Nara , Yutaka Kanda , Hiroshi Umehara , Yukimasa Shiotsu , Tomoki Naoe , Hitoshi Kiyoi , Keiko Kawashima , Hiromi Ando , Motoki Miyama
IPC分类号： A61K31/5377 , A61K31/416 , A61K31/496 , A61K31/454 , A61K31/506 , A61K31/4439 , A61P35/00
CPC分类号： C07D231/56
摘要： The present invention provides a compound represented by Formula (I): [wherein R1 represents CONR1aR1b (wherein R1a and R1b may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted ararkyl or a substituted or unsubstituted heterocyclic group, or R1a and R1b are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group) or the like, R2 represents a hydrogen atom, CONR2aR2b (wherein R2a and R2b may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted ararkyl or a substituted or unsubstituted heterocyclic group, or R2a and R2b are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group), NR2cR2d (wherein R2c and R2d may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkanoyl, substituted or unsubstituted aroyl, substituted or unsubstituted heteroaroyl, substituted or unsubstituted ararkyl, substituted or unsubstituted lower alkylsulfonyl or substituted or unsubstituted lower arylsulfonyl) or the like].
摘要翻译：本发明提供由式（I）表示的化合物：[其中R1表示CONR1aR1b（其中R1a和R1b可以相同或不同，各自表示氢原子，取代或未取代的低级烷基，取代或未取代的芳基，取代或未取代的芳基或取代或未取代的杂环基，或者R1a和R1b与相邻的氮原子一起形成取代或未取代的杂环基）等，R2表示氢原子，CONR2aR2b（其中R2a和R2b可以是各自表示氢原子，取代或未取代的低级烷基，取代或未取代的芳基，取代或未取代的芳基或取代或未取代的杂环基，或者R 2a和R 2b与相邻的氮原子一起形成取代基或未取代的杂环基），NR2cR2d（其中R2c和R2d可以相同或不同取代或未取代的芳酰基，取代或未取代的芳酰基，取代或未取代的低级烷基磺酰基或取代或未取代的低级芳基磺酰基）等。。

8. 发明授权

US07470717B2 Indazole derivatives 失效
标题翻译：吲唑衍生物
公开(公告)号：US07470717B2
公开(公告)日：2008-12-30
申请号：US10548475
申请日：2004-07-30
申请人： Yoshihisa Ohta , Fumihiko Kanai , Shinji Nara , Yutaka Kanda , Hiroshi Umehara , Yukimasa Shiotsu , Tomoki Naoe , Hitoshi Kiyoi , Keiko Kawashima , Hiromi Ando , Motoki Miyama
发明人： Yoshihisa Ohta , Fumihiko Kanai , Shinji Nara , Yutaka Kanda , Hiroshi Umehara , Yukimasa Shiotsu , Tomoki Naoe , Hitoshi Kiyoi , Keiko Kawashima , Hiromi Ando , Motoki Miyama
IPC分类号： A61K31/416 , C07D231/56
CPC分类号： C07D231/56
摘要： The present invention provides a compound represented by Formula (I): [wherein R1 represents CONR1aR1b (wherein R1a and R1b may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted ararkyl or a substituted or unsubstituted heterocyclic group, or R1a and R1b are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group) or the like, R2 represents a hydrogen atom, CONR2aR2b (wherein R2a and R2b may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted ararkyl or a substituted or unsubstituted heterocyclic group, or R2a and R2b are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group), NR2cR2d (wherein R2c and R2d may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkanoyl, substituted or unsubstituted aroyl, substituted or unsubstituted heteroaroyl, substituted or unsubstituted ararkyl, substituted or unsubstituted lower alkylsulfonyl or substituted or unsubstituted lower arylsulfonyl) or the like].
摘要翻译：本发明提供由式（I）表示的化合物：[其中R1表示CONR1aR1b（其中R1a和R1b可以相同或不同，各自表示氢原子，取代或未取代的低级烷基，取代或未取代的芳基，取代或未取代的芳烷基或取代或未取代的杂环基，或者R1a和R1b与相邻的氮原子一起形成取代或未取代的杂环基）等，R2表示氢原子，CONR2aR2b（其中R2a和R2b可以是各自表示氢原子，取代或未取代的低级烷基，取代或未取代的芳基，取代或未取代的芳烷基或取代或未取代的杂环基，或R 2a和R 2b与相邻的氮原子一起形成取代基或未取代的杂环基），NR2cR2d（其中R2c和R2d可以相同或不同取代或未取代的杂芳酰基，取代或未取代的芳烷基，取代或未取代的低级烷基磺酰基或取代或未取代的低级芳基磺酰基）等，其中R 1代表氢原子，取代或未取代的低级烷基，取代或未取代的低级烷酰基，取代或未取代的芳酰基，。

9. 发明申请

US20090209537A1 AURORA INHIBITORS 审中-公开
标题翻译： AURORA抑制剂
公开(公告)号：US20090209537A1
公开(公告)日：2009-08-20
申请号：US12305120
申请日：2007-06-29
申请人： Yukimasa Shiotsu , Kenichi Ishii , Hiroshi Umehara
发明人： Yukimasa Shiotsu , Kenichi Ishii , Hiroshi Umehara
IPC分类号： A61K31/5377 , A61P35/00
CPC分类号： C07D403/10 , A61K31/416 , A61K31/4439 , A61K31/454 , A61K31/496 , A61K31/5377 , C07D231/56 , C07D401/06
摘要： The present invention provides an Aurora inhibitor which comprises, as an active ingredient, an indazole derivative represented by Formula (I) (wherein R1 represents substituted or unsubstituted aryl or a substituted or unsubstituted heterocyclic group) or a pharmaceutically acceptable salt thereof, an Aurora inhibitor which comprises, as an active ingredient, an indazole derivative represented by Formula (Ia) [wherein R2 represents CONR4aR4b (wherein R4a and R4b may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like, or R4a and R4b are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group) or the like, and R3 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like] or a pharmaceutically acceptable salt thereof, and the like.
摘要翻译：本发明提供一种Aurora抑制剂，其包含作为活性成分的由式（I）表示的吲唑衍生物（其中R 1表示取代或未取代的芳基或取代或未取代的杂环基）或其药学上可接受的盐，极光抑制剂其包含作为活性成分的由式（Ia）表示的吲唑衍生物[其中R2表示CONR4aR4b（其中R4a和R4b可以相同或不同，各自表示氢原子，取代或未取代的低级烷基等，或R4a和R4b与相邻的氮原子一起形成取代或未取代的杂环基）等，R 3表示氢原子，取代或未取代的低级烷基等]或其药学上可接受的盐，等等。

10. 发明申请

US20060281789A1 Protein kinase inhibitors 审中-公开
标题翻译：蛋白激酶抑制剂
公开(公告)号：US20060281789A1
公开(公告)日：2006-12-14
申请号：US10548592
申请日：2004-07-30
申请人： Yukimasa Shiotsu , Hiroshi Umehara , Fumihiko Kanai , Shinji Nara , Yoshihisa Ohta , Yutaka Kanda , Shiro Akinaga , Tomoki Naoe , Hitoshi Kiyoi , Tomoyuki Nakazato , Satoshi Tashiro
发明人： Yukimasa Shiotsu , Hiroshi Umehara , Fumihiko Kanai , Shinji Nara , Yoshihisa Ohta , Yutaka Kanda , Shiro Akinaga , Tomoki Naoe , Hitoshi Kiyoi , Tomoyuki Nakazato , Satoshi Tashiro
IPC分类号： A61K31/4439 , C07D403/02
CPC分类号： C07D231/56
摘要： The present invention provides a protein kinase inhibitor (excluding c-Jun N-terminal kinase inhibitor) which comprises, as an active ingredient, an indazole derivative represented by Formula (I) (wherein R1 represents substituted or unsubstituted aryl or a substituted or unsubstituted heterocyclic group) or a pharmaceutically acceptable salt thereof.
摘要翻译：本发明提供一种蛋白激酶抑制剂（不包括c-Jun N-末端激酶抑制剂），其包含作为活性成分的由式（I）表示的吲唑衍生物（其中R 1表示取代或未取代的芳基或取代或未取代的杂环基）或其药学上可接受的盐。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式